Current Report Filing (8-k)
19 August 2017 - 6:47AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
August 15, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
333-192989
|
|
22-3832302
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
[X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Item
1.01
|
Entry
into a Material Definitive Agreement
|
On
August 15, 2017, Medical Transcription Billing, Corp. (“MTBC” or the “Company”) entered into a Placement
Agency Agreement (the “Agreement”) with Alexander Capital, LP., pursuant to which the Company agreed to issue and
sell 23,695 shares of its 11% Series A Cumulative Redeemable Preferred Stock in a public offering pursuant to a Registration Statement
on Form S-3 (File No. 333-210391) and a related prospectus, including the related prospectus supplement, filed with the Securities
and Exchange Commission.
The
net proceeds of the offering to the Company were approximately $500,000, after deducting placement agency fees and other estimated
offering expenses. The Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
In
connection with the offering referenced above, the legal opinion as to the legality of the series A preferred stock sold is being
filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein and into the Registration Statement by reference.
Item
9.01
|
Financial
Statements and Exhibits
|
|
1.1
|
Medical
Transcription Billing, Corp. Placement Agency Agreement dated as of August 15, 2017.
|
|
|
|
|
5.1
|
Opinion
of Mazzeo Song P.C.
|
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical Transcription Billing, Corp.
|
|
|
|
Date:
August 18, 2017
|
By:
|
/s/
Mahmud Haq
|
|
|
Mahmud
Haq
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Sep 2024 to Oct 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about CareCloud Inc (NASDAQ): 0 recent articles
More Medical Transcription Billing, Corp News Articles